HBIO
Price
$0.45
Change
-$0.01 (-2.17%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
20.38M
43 days until earnings call
IRMD
Price
$70.04
Change
-$1.53 (-2.14%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
910.37M
37 days until earnings call
Interact to see
Advertisement

HBIO vs IRMD

Header iconHBIO vs IRMD Comparison
Open Charts HBIO vs IRMDBanner chart's image
Harvard Bioscience
Price$0.45
Change-$0.01 (-2.17%)
Volume$1.35K
Capitalization20.38M
iRadimed
Price$70.04
Change-$1.53 (-2.14%)
Volume$600
Capitalization910.37M
HBIO vs IRMD Comparison Chart in %
Loading...
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HBIO vs. IRMD commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBIO is a Hold and IRMD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (HBIO: $0.46 vs. IRMD: $71.57)
Brand notoriety: HBIO and IRMD are both not notable
HBIO represents the Pharmaceuticals: Other, while IRMD is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: HBIO: 58% vs. IRMD: 126%
Market capitalization -- HBIO: $20.38M vs. IRMD: $910.37M
HBIO [@Pharmaceuticals: Other] is valued at $20.38M. IRMD’s [@Medical/Nursing Services] market capitalization is $910.37M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $160.51B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $236.51B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.14B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HBIO’s FA Score shows that 1 FA rating(s) are green whileIRMD’s FA Score has 2 green FA rating(s).

  • HBIO’s FA Score: 1 green, 4 red.
  • IRMD’s FA Score: 2 green, 3 red.
According to our system of comparison, IRMD is a better buy in the long-term than HBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HBIO’s TA Score shows that 5 TA indicator(s) are bullish while IRMD’s TA Score has 3 bullish TA indicator(s).

  • HBIO’s TA Score: 5 bullish, 4 bearish.
  • IRMD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, HBIO is a better buy in the short-term than IRMD.

Price Growth

HBIO (@Pharmaceuticals: Other) experienced а -5.61% price change this week, while IRMD (@Medical/Nursing Services) price change was +0.15% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.60%. For the same industry, the average monthly price growth was -2.17%, and the average quarterly price growth was +9.10%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.84%. For the same industry, the average monthly price growth was +5.78%, and the average quarterly price growth was +11.05%.

Reported Earning Dates

HBIO is expected to report earnings on Nov 06, 2025.

IRMD is expected to report earnings on Oct 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.60% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+1.84% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRMD($910M) has a higher market cap than HBIO($20.4M). IRMD YTD gains are higher at: 31.249 vs. HBIO (-78.308). IRMD has higher annual earnings (EBITDA): 24.6M vs. HBIO (-46.8M). IRMD has more cash in the bank: 53M vs. HBIO (7.44M). IRMD has less debt than HBIO: IRMD (0) vs HBIO (43.3M). HBIO has higher revenues than IRMD: HBIO (88.8M) vs IRMD (77.6M).
HBIOIRMDHBIO / IRMD
Capitalization20.4M910M2%
EBITDA-46.8M24.6M-190%
Gain YTD-78.30831.249-251%
P/E RatioN/A44.45-
Revenue88.8M77.6M114%
Total Cash7.44M53M14%
Total Debt43.3M0-
FUNDAMENTALS RATINGS
HBIO vs IRMD: Fundamental Ratings
HBIO
IRMD
OUTLOOK RATING
1..100
8275
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
68
Overvalued
PROFIT vs RISK RATING
1..100
10021
SMR RATING
1..100
9940
PRICE GROWTH RATING
1..100
8844
P/E GROWTH RATING
1..100
220
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IRMD's Valuation (68) in the Medical Specialties industry is in the same range as HBIO (100) in the Biotechnology industry. This means that IRMD’s stock grew similarly to HBIO’s over the last 12 months.

IRMD's Profit vs Risk Rating (21) in the Medical Specialties industry is significantly better than the same rating for HBIO (100) in the Biotechnology industry. This means that IRMD’s stock grew significantly faster than HBIO’s over the last 12 months.

IRMD's SMR Rating (40) in the Medical Specialties industry is somewhat better than the same rating for HBIO (99) in the Biotechnology industry. This means that IRMD’s stock grew somewhat faster than HBIO’s over the last 12 months.

IRMD's Price Growth Rating (44) in the Medical Specialties industry is somewhat better than the same rating for HBIO (88) in the Biotechnology industry. This means that IRMD’s stock grew somewhat faster than HBIO’s over the last 12 months.

HBIO's P/E Growth Rating (2) in the Biotechnology industry is in the same range as IRMD (20) in the Medical Specialties industry. This means that HBIO’s stock grew similarly to IRMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HBIOIRMD
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
61%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend about 1 month ago
73%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 10 days ago
85%
Bearish Trend 8 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
61%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RMD275.611.20
+0.44%
ResMed
CBT76.460.20
+0.26%
Cabot Corp
SLRC15.68-0.15
-0.95%
SLR Investment Corp
HIT3.39-0.08
-2.31%
Health In Tech Inc
SEGG5.06-0.39
-7.16%
Lottery. com Inc

HBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HBIO has been loosely correlated with IRMD. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if HBIO jumps, then IRMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HBIO
1D Price
Change %
HBIO100%
-3.97%
IRMD - HBIO
51%
Loosely correlated
+1.22%
SGHT - HBIO
39%
Loosely correlated
-1.95%
A - HBIO
38%
Loosely correlated
-0.31%
TMO - HBIO
35%
Loosely correlated
-1.10%
MTD - HBIO
35%
Loosely correlated
-0.08%
More

IRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with HBIO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then HBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
+1.22%
HBIO - IRMD
51%
Loosely correlated
-3.97%
TWST - IRMD
44%
Loosely correlated
-0.61%
ICUI - IRMD
43%
Loosely correlated
-1.49%
ZIMV - IRMD
43%
Loosely correlated
+0.11%
ATRC - IRMD
42%
Loosely correlated
-2.35%
More